Cite
Fang J, Zhang P, Wang Q, et al. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease. Alzheimers Res Ther. 2022;14(1):7doi: 10.1186/s13195-021-00951-z.
Fang, J., Zhang, P., Wang, Q., Chiang, C. W., Zhou, Y., Hou, Y., Xu, J., Chen, R., Zhang, B., Lewis, S. J., Leverenz, J. B., Pieper, A. A., Li, B., Li, L., Cummings, J., & Cheng, F. (2022). Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease. Alzheimer's research & therapy, 14(1), 7. https://doi.org/10.1186/s13195-021-00951-z
Fang, Jiansong, et al. "Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease." Alzheimer's research & therapy vol. 14,1 (2022): 7. doi: https://doi.org/10.1186/s13195-021-00951-z
Fang J, Zhang P, Wang Q, Chiang CW, Zhou Y, Hou Y, Xu J, Chen R, Zhang B, Lewis SJ, Leverenz JB, Pieper AA, Li B, Li L, Cummings J, Cheng F. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease. Alzheimers Res Ther. 2022 Jan 10;14(1):7. doi: 10.1186/s13195-021-00951-z. PMID: 35012639; PMCID: PMC8751379.
Copy
Download .nbib